Enrofloxacin is one of the second-generation quinolones with extended antibacterial activity not only against gram positive and gram negative bacteria, but also against mycoplasma. It is well absorbed and distributed after oral and parenteral dosing. Enrofloxacin acts by inhibiting bacterial DNA-gyrase, leading to a reduction in supercoiling and serious disruption of the spatial arrangement of DNA.